S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CNTX Context Therapeutics Inc

0.80

-0.031 (-3.73%)

Mar 07 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Context Therapeutics Charts.

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Context Therapeutics Charts.

Context Therapeutics Inc News

Form 8-K - Current report
Friday 28 February 2025 (1 week ago) • Edgar (US Regulatory)

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Monday 24 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Context Therapeutics to Participate in Upcoming Investor Conferences
Wednesday 19 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
Tuesday 14 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 13 January 2025 (2 months ago) • Edgar (US Regulatory)

Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of Directors
Monday 13 January 2025 (2 months ago) • GlobeNewswire Inc.

More Context Therapeutics Inc News Articles

Banque Palatine null

Vinci 2.02% 28nov2034

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions